Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Novel phosphate adsorbers for the treatment of patients with renal failure

Dec. 5, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders

Nov. 22, 2013

European Commission approves Prilocaine Lidocaine Plethora for premature ejaculation

Nov. 19, 2013

Toray Industries divulges novel soluble epoxide hydrolase inhibitors

Nov. 18, 2013

Kyowa Hakko Kirin discontinues phase II studies of bardoxolone methyl

Nov. 12, 2013

Keryx Biopharmaceuticals provides update from safety extension study of Zerenex

Nov. 12, 2013

New Hsp70 inducers presented by scientists in the Netherlands

Nov. 11, 2013

Phase II trial of Zerenex in NDD-CKD meets all primary and key secondary endpoints

Nov. 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...